Establishing the standards of operational excellence to manufacture commercial cell therapies

Hui Zheng joined Lonza in 2021 and is currently serving as the Head of Operations, CGT at Lonza Singapore. She drives operational excellence and ensures top-quality manufacturing processes. With extensive experience and leadership roles at Novartis, including Head of Project Management Office and Head of operational excellence, Hui has a proven track record of successful project execution. Her Master's degree in Biochemical Engineering from Tianjin University added a solid academic foundation to her practical expertise. Known for her dedication and innovation, Hui Zheng continues to make significant contributions to advancing Cell & Gene therapies.

Melanie Mansbach is a dedicated leader with a career spanning over 15 years, including experience in cell and gene therapy manufacturing and in the U.S. Army. As the Head of Cell Therapy Manufacturing at Lonza Houston, she leads a 250-person team in the production of cell therapy products under cGMP. Her expertise in this specialized field, coupled with her proven track record of team development and process improvement, has consistently delivered outstanding results. Melanie's exceptional leadership and deep knowledge of cell and gene therapy manufacturing continue to drive transformative advancements in the industry.